Litcius/Paper detail

Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety

Young R. Lee, Suyeon Yeo

2020Clinical Drug Investigation46 citationsDOIOpen Access PDF

Topics & Concepts

Pseudomonas aeruginosaCephalosporinMicrobiologyProteus mirabilisAcinetobacter baumanniiImipenemMedicineEnterobacter cloacaeStenotrophomonas maltophiliaEnterobacterKlebsiella pneumoniaeMeropenemBiologyAntibioticsAntibiotic resistanceBacteriaEscherichia coliBiochemistryGeneticsGeneAntibiotic Resistance in BacteriaUrinary Tract Infections ManagementAntibiotics Pharmacokinetics and Efficacy
Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety | Litcius